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Available online 12 May 2016In the present study, blend of poly L-lactic acid (PLLA) with a graft copolymer based on α,β-poly(N-
hydroxyethyl)-DL-aspartamide and PLA named PHEA-PLA, has been used to design porous scaffold by using
Thermally Induced Phase Separation (TIPS) technique.
Starting from a homogeneous ternary solution of polymers, dioxane and deionised water, PLLA/PHEA-PLA porous
foamshave beenproduced by varying the polymers concentration andde-mixing temperature inmetastable region.
Results have shown that scaffolds preparedwith a polymer concentration of 4% andde-mixing temperature of 22.5 °
C are the best among those assessed, due to their optimal pore size and interconnection. SEM andDSC analysis have
been carried out respectively to study scaffold morphology and the inﬂuence of PHEA-PLA on PLLA crystallization,
while DMF extraction has been carried out in order to quantify PHEA-PLA into the ﬁnal scaffolds.
To evaluate scaffold biodegradability, a hydrolysis study has been performed until 56 days by incubating systems
in a media mimicking physiological environment (pH 7.4). Results obtained have highlighted a progressive in-
crease in weight loss with time in PLLA/PHEA-PLA scaffolds, conceivably due to the presence of PHEA-PLA and
polymers interpenetration. Viability and adhesion of bovine chondrocytes seeded on the scaffolds have been
studied byMTS test and SEM analysis. From results achieved it appears that the presence of PHEA-PLA increases
cells afﬁnity, allowing a faster adhesion and proliferation inside the scaffold.
© 2016 Elsevier B.V. All rights reserved.Keywords:
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Bone and cartilage engineered tissues have been developed as
alternatives to autografts and allografts to repair and reconstruct
osteochondral defects. Tissue engineering involves the in vitro seeding
of cells onto scaffolds supporting their adhesion, migration, prolifera-
tion and differentiation, and deﬁnes the three dimensional (3D) shape
of the tissue to be engineered [1]. The optimal scaffold should be bio-
compatible, biodegradable and cell-conductive to stimulate new tissue
formation [2]. To secure a high density of colonizing cells and to pro-
mote neovascularization when implanted in vivo, the scaffolds should
have optimal mechanical properties, large surface area and pore size
distribution as well as a highly interconnected porous structure [3].
Thermally induced phase separation (TIPS) can be employed in
order to produce a well interconnected porous structure as tissue engi-
neering scaffold. In fact, TIPS is a very convenient methodology forrmo, Italy.
Palumbo).fabricating porousmaterials as scaffold architectures that can be obtain-
ed by means of the manipulation of processing parameters and system
properties. TIPS technique is based on thermodynamic demixing of a
homogeneous polymer-solvent solution into a polymer-rich phase and
a polymer-lean phase, usually by either exposure of the solution to
another immiscible solvent or cooling the solution below a binodal
solubility curve [4]. A variety of polymers such as polyesters have
been employed as well as blends and composite of polymers with
nanohydroxyapatite [5,6]. Poly(L-lactide) (PLLA) has been widely used
as a scaffold material for bone and cartilage tissue engineering because
of its superior mechanical properties, well-known biodegradability and
biocompatibility [7,8,9]. PLLA is derived from 100% renewable resources
and could be eventually degraded into CO2 and H2O under natural con-
ditions [10,11]. However, the acid degradation products and mostly
poor cell afﬁnities limit the scope in tissue engineering applications
[12]. In contrast, different polysaccharides such as chitosan have been
commonly used with polylactide for improving the cytocompatibility
and neutralizing the acid degradation products of polylactides in bio-
medical application [5,13].
562 F. Carfì Pavia et al. / Materials Science and Engineering C 67 (2016) 561–569In the past decades, functionalized biodegradable polymers have
attracted much attention. In particular, R-amino acid have been used as
a building blocks for constructing biodegradable polymers to mainly im-
part chemical functionality, such as hydroxyl, amine, carboxyl or and thiol
groups. These functionalized biodegradable polymers not only result in
improved hydrophilicity and possible interactions with proteins and
genes, but also facilitates further modiﬁcation with bioactive molecules
[14]. In this context, α,β-poly(N-hydroxyethyl)-DL-aspartamide (PHEA)
is a biocompatible protein-like copolymer showing water solubility, ab-
sence of toxicity, antigenicity and teratogenicity. PHEA has been success-
fully used as starting material to generate different graft copolymers
for several biomedical and pharmaceutical applications [15]. In previous
papers has been demonstrated that the presence of the synthetic
polyaminoacids appropriately allowed to tune cell adhesiveness together
with chemical, physical and mechanical properties [16,17,18].
The aim of this paper is to prepare porous biodegradable scaffolds via
TIPS starting from a blend of PLLAwith a graft copolymer based on PHEA
and PLA named PHEA-PLA [19], in the proportion of 75:25 (wt/wt). The
goal is to develop new composite scaffolds exhibiting processability,
workability stiffness and biocompatibility proper of PLLA together with
chemical versatility, higher water afﬁnity and faster rate of hydrolysis of
PHEA in physiologic media, moreover improving the scaffold cellular af-
ﬁnity [19]. In fact, adhesion of tissue cells to biomaterials is a prerequisite
of paramount importance for the successful incorporation of implants
and the colonization of scaffolds in tissue engineering applications. First,
PLLA/PHEA-PLA porous foams have been produced via TIPS by varying
the polymers concentration and resident temperature in metastable re-
gion to control the ﬁnal structure in terms of complexmorphology, aver-
age pore size and degree of interconnection, according to a protocol
already developed by the authors for PLLA [20,21]. Second, an investiga-
tion regarding the in vitro degradation rate of the blends has been carried
out. As a preliminary assay short term viability and above all adhesion of
bovine chondrocytes seeded in the scaffolds have been conﬁrmed byMTS
test and SEM analysis.
2. Materials and Methods
2.1. Materials
All reagents were of analytical grade unless otherwise
stated. Dimethyl sulfoxide (DMSO), dichloromethane (CH2Cl2),
ethanol, N,N1-dimethylformamide (DMF), diethyl ether, N-N1-
dicyclohexylcarbodiimide (DCC), N-hydroxysuccinimide (NHS),
Dulbecco's Phosphate Buffered Saline (DPBS) were obtained from
Sigma–Aldrich (Italy). Diethylamine (DEA) was purchased from
Fluka (Italy).
α,β-Poly(N-2-hydroxyethyl)-D,L-aspartamide (PHEA) was prepared
and puriﬁed according to a procedure reported elsewhere [22]. Spectro-
scopic data (FT-IR and 1H NMR) were in agreement with previous
results [23]. PHEA weight-average molecular weight was 38 kDa (Mw/
Mn = 1.78) as determined by size exclusion chromatography.
PURASORB® PDL 02 A (acid terminated GMP grade copolymer of DL-
lactide 14 kDa) was purchased from Corbion Purac. PLLA (RESOMERTN
L 209S) supplied by Boehringer Ingelheim Pharma KG, 1,4 dioxane
(Sigma) and double distilled water were utilized to prepare the ternary
solution. Chondrocytes were cultured in Dulbecco's modiﬁed Eagle's
medium (DMEM) supplemented with 10% fetal bovine serum (FBS),
1% L-glutamine and 1% penicillin/streptomycin and 0.25% amphotericin
B, purchased from Euroclone (Milan, Italy).
2.2. Apparatus
FT-IR spectra were carried out by using a Brucker Alpha instrument.
Proton nuclear magnetic resonance (1H NMR) was performed using a
Brucker AC-300 instrument of 300 MHz.Size exclusion chromatography (SEC) was performed using
an Agilent 1260 Inﬁnity Multi-Detector Bio-SEC solution. SEC system
was equipped with a pump system, two Phenogel columns from
Phenomenex (5 μm particle size, 103 Å and 104 Å of pores size), and
Bio-Dual Angle LS/DLS and RI Detector. Analyses were performed
with 0.1 M LiBr DMF solution as eluent with a ﬂow of 0.6 ml/min and
poly(ethylene oxide) standards (range 145 and 1.5 kDa) to obtain the
calibration curve. The column temperature was set at 60 °C (±0.1 °C).
The morphology of the samples was analysed by Scanning Electron
Microscopy (SEM) using a SEM-FEI QUANTA 200F on sample cross sec-
tion fractured in liquid nitrogen and gold sputtered (Sputtering
Scancoat Six, Edwards) for 40 s under Argon atmosphere before
imaging.
A Setaram 131 evo Differential Scanning Calorimeter was used to
attain scaffold melting thermograms. The samples were heated from 60
to 210 °C at a rate of 10 °C/min, under a nitrogen gas ﬂow of 1 ml/min.
2.3. Synthesis and characterization of PHEA-PLA graft copolymer
The synthesis of PHEA-PLA graft copolymer was performed similarly
to how reported elsewhere [19]. A solution of 600 mg of PHEA in 12 ml
of anhydrousDMSO containing 576 μl of DEA as a catalystwas prepared.
PLA N-hydroxysuccinimide (NHS) derivative (i.e. PLA-NHS) was
prepared and puriﬁed according to a procedure reported elsewhere
[19,24]; then a suitable amount of PLA–NHS in 12 ml of anhydrous
DMSO was added to obtain a ratio (X) between moles of PLA–NHS
andmoles of PHEA repeating units equal to 0.1. The reactionwas carried
out under argon at 40 °C for 24 h. PHEA–PLA copolymerwaspuriﬁed fol-
lowing a different procedure. First the reaction solutionwas dialyzed by
using dialysis tubes (Visking) with a cutoff of 25,000 Da against DMSO
for three days, then it was dialyzed by using dialysis tubes with a cutoff
of 12,000–14,000 Da against water to remove the organic solvent. The
obtained suspension was freeze-dried, and then the product was dis-
solved in DMF and precipitated in diethyl ether. The recovered solid
was washed twice in diethyl ether dichloromethane mixture (15:1
vol/vol) and in diethyl ether, then dried under vacuum. The puriﬁed
product was ﬁnally characterized by FT-IR, 1H NMR.
FT-IR spectra (KBr) of PHEA–PLA graft copolymer showed a broad
band centred at 3450 cm−1 (νas OH + νas NH of PHEA), bands at 1760
(νas COO of PLA), 1655 (amide I of PHEA), 1542 (amide II of PHEA),
1457 (δas CH3 of PLA), 1383 (δs CH3 of PLA), 1183 (νs C–O–C ester
group of PLA), 1089 (ν C\\O alcoholic of PHEA) cm−1.
1H NMR spectra of PHEA–PLA graft copolymer (in DMSO-d6)
showed: δ 1.25 and δ 1.45 (2d, –O–CO–CH(CH3)–O– of PLA), δ 3.1 (m,
2H –NH–CH2–CH2–OH of PHEA), δ 4.6 (m, 1H, NH–CH(CO)CH2– of
PHEA), δ 4.1 and δ 5.1 (m, 1H, –O–CO–CH(CH3)–OH and m, 1H, –O–
CO–CH(CH3)–O– of PLA). The degree of derivatization percentage
(DD%) in PLA was expressed as:
DD% ¼ moles PLA chains=moles of repeating units of PHEAð Þ 100 ð1Þ
This ratio was calculated by comparing the integral of two peaks re-
lated to protons attributable tomethyl groups of PLA chain at δ 1.25 and
1.45,with the integral of protons at δ 3.1 attributable to –NH–CH2–CH2–
OH belonging to the ethanolamine groups of PHEA.
PHEA-PLA copolymer was obtained with a yield of 260% (w/w)
based on the starting PHEA.
To conﬁrm that PHEA-PLA copolymer maintains its stability after
120 min at the temperature of 65 °C (process temperature), Size Exclu-
sion Chromatographic (SEC) analysis was performed. Two aliquots of
PHEA-PLA copolymer were dispersed in dioxane-deionised water mix-
ture 87/13 (wt/wt) at 65 °C for deﬁned time points (5 and 120 min
after complete solubilisation). Both samples were treated to remove
solvents and the solid recoveredwas solubilized in 0.1M LiBr DMF solu-
tion. SEC analysis was performed and peak max retention time (min)
and peak area (mV·s) have been evaluated.
Table 1
PHEA-PLA SEC data recovered after 5 and 120 min at 65 °C.
Treatment time (min) MW (Daltons) Peak max RT (min) Peak area (mV·s)
5 116,431 19.55 9033.044
120 111,907 19.57 9204.447
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A homogeneous ternary solution composed of PLLA/PHEA–PLA
(75/25), 1,4 dioxane and deionised water was preparedwith a constant
dioxane to water weight ratio of 87/13 (wt/wt) based on previous liter-
ature studies on the same system [25,26]. Polymer concentration was
chosen to be 4%, 5% and 6% (wt/wt). The solution, initially kept at 65 °
C, was hot poured into a disc-shaped aluminium sample holder (diam-
eter 10 mm, thickness 2 mm). The temperature was then suddenly
lowered to 22.5, 25, 30 or 33 °C (demixing temperature) for a well-
deﬁned demixing time (30min), by pool immersion of the sample hold-
er into a thermostatic water bath, according to a protocol developed by
the authors and described in detail elsewhere [26]. Then a quench by
pool immersion in an ethyl alcohol bath at a temperature of −20 °C
for 15 min was performed in order to freeze the as-obtained structure.
Finally, the as-obtained scaffolds were subjected to washings in
deionised water for 24 h and drying at 20 °C under vacuum overnight,
in order to completely remove any remaining solvent trace.Fig. 1. SEM images of PLLA/PHEA-PLA scaffolds obtained at different polymer concThe morphology of the samples was analysed by SEM and obtained
images were exported as 24-bit image ﬁles using the tagged image ﬁle
format (tiff). The melting thermograms, temperatures and enthalpies
of the samples were determined with a DSC analysis.
In order to quantify the presence of PHEA-PLA into the blend scaf-
folds, theywere processedwith DMFunder stirring over night to extract
PHEA-PLA fraction. After this time, extracted PHEA-PLA was precipitat-
ed in deionised water and freeze-dried, while residual scaffolds were
washed several time with deionised water, then with ethanol and
dried under vacuum. FT-IR, DSC and SEM analysis were performed on
residual scaffolds; scaffolds recovered weight was compared to the
starting dry weight of the samples. As comparison, the same treatment
was performed on PLLA scaffolds obtained at polymer concentration of
4% wt/wt, demixing temperature equal to 30 °C and demixing time of
45 min.
2.5. Scaffold hydrolysis and weight loss studies
To evaluate rate of scaffold hydrolysis under body ﬂuid-like condi-
tion, PLLA/PHEA-PLA scaffolds (10 mm large and wide, 2 mm thick)
were weighed (Wi) and kept in a 24 well plate ﬁlled by 1 ml of DPBS
pH 7.4. Samples were left under stirring (100 rpm) in an orbital shaker
at 37 °C until 56 days. The liquid into the wells was changed every two
days. After each incubation time, the samples were weighted (WS) and
were washed several time with deionised water to extract salts andentrations (6%, 5% and 4%) and demixing temperature (33, 30, 25 or 22.5 °C).
Fig. 2. A: DSC thermograms of virgin PLLA, virgin PHEA-PLA and PLLA/PHEA–PLA scaffold; B: Peak deconvolution of the thermogram of PLLA/PHEA-PLA scaffold.
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under vacuum. Finally, the dried samples were weighed (WT). The
swelling behaviour was expressed as the swelling weight ratio (q) be-
tweenWS andWi. Theweight loss (%) of the residues after the hydroly-
sis was expressed as mass washed out from the scaffolds respect to the
starting dry weight of the sample. Also, IR analysis on residual scaffolds
was performed. For this study, PLLA scaffolds have been used as
comparison.
2.6. Isolation of bovine chondrocytes
Articular cartilage was cut from the metacarpophalangeal joint of
bovine feet obtained from a local abattoir and usedwithin 12 h. The car-
tilage was dissected, reduced in small pieces with a scalpel and treatedfor 3 min with a cold ethanol solution (70% v/v in sterile DPBS pH 7.4).
Pieces were then washed several times with sterile DPBS pH 7.4 and in-
cubated at 37 °C for 1 h with a solution containing 20 U/ml of Dispase
(Sigma-Aldrich) in complete DMEM, i.e. DMEM supplemented with
10% v/v of fetal bovine serum (FBS), 1% v/v of penicillin/streptomycin
solution (100 U ml-1 penicillin and 100 μg ml-1 streptomycin), 1% v/v
of glutamine and 0.1% v/v amphotericin B solution [27,28]. After, carti-
lage pieces were incubated for further 18 h with a solution of type I
collagenase (64 U/ml) (from clostridium histolyticum) (Sigma-Aldrich)
in complete DMEM. After the enzymatic digestion, the medium was
ﬁltered through a sterile ﬁlter (120 μm), chondrocytes were collected
by centrifugation (1500 rpm for 5 min), suspended in fresh complete
DMEM and seeded in T-75 culture ﬂasks. Isolated chondrocytes were
used between passages 3 and 4 [28].
Fig. 3. FT-IR overlay spectra of PLLA/PHEA-PLA scaffold before (dash line) and after
(continuous line) DMF treatment. Peaks at 1665 cm−1 and 1542 cm−1 are attributable
to the amide I and II of PHEA.
Fig. 4. DSC thermograms of pure PLLA and PLLA/PHEA-PLA scaffolds before and after the
DMF treatment.
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Chondrocytes were treated with trypsin and their number was
determined by using a Bürker chamber, then they were suspended in
complete DMEM. Blend scaffolds were sterilized by ethanol 70% (v/v)
solution so they werewashed with sterile DPBS. Therefore an appropri-
ate volume of cell suspension was added on the top of scaffolds, at den-
sity of 1·105 cells/scaffold. After 1 h, scaffolds were placed into 24 well
plate and 1 ml of complete DMEM was added. Incubation was left at
37 °C and 5% of CO2. PLLA scaffolds as comparison model have been
used.
Viability of chondrocytes seeded into PLLA/PHEA-PLA and PLLA
scaffolds was investigated at established time points (after 24,
48 and 72 h) by MTS assay (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4sulfophenyl)-2H-tetrazolium assay
(CellTiter 96® AQueous One Solution Cell Proliferation, PROMEGA)
following the manufacturer instructions. Each cell proliferation
assay was performed in triplicate and results were reported as ab-
solute optical density measured at 490 nm.
A SEM analysis was performed to observe chondrocytes after 24 h of
incubation into PLLA/PHEA-PLA and PLLA scaffolds. Samples were
washed with fresh DPBS pH 7.4 and ﬁxed with formalin 4% (v/v) at 4 °
C for 2 h, then were rinsed with water and dehydrated with ethanol se-
ries (25%, 50%, 75% v/v and pure ethanol). Finally samples were treated
with hexamethyldisilazane (Sigma-Aldrich), dried under vacuum prior
to be gold sputtered and analysed by SEM [24].
2.8. Statistical analysis
All the experiments were repeated at least three times. All results
were reported asmeans± standard deviation (S.D.) and, when applica-
ble, statistical analysis for signiﬁcance was performed by means of
the Student's t-test, using Microsoft Excel statistical function for t tests,
assuming unequal variance and two-tailed distribution; values of
p b 0.05 were considered statistically signiﬁcant while a p-value b 0.01
was considered as highly signiﬁcant.
3. Results and discussion
3.1. Scaffolds preparation and characterization
Aim of this work was to use a blend of high molecular weight
L-polylactic acid (PLLA) with PHEA-PLA graft copolymer to create a hy-
brid porous scaffold combining favourable properties of crystalline PLLA
for TIPS processing with favourable properties of the amorphous PHEA-
PLA in terms ofwater afﬁnity and timeof reabsorption. Interpenetration
between the two polymers could give peculiar physical characteristics
suitable to improve scaffold water afﬁnity and rate of hydrolysis of
blended scaffold if compared to PLLA scaffold alone. In our previous
work a graft derivative of PHEA and crystalline PLLA was successfully
employed for the production of scaffold through the TIPS technique
[29]. Here instead an amorphous derivative of PHEA obtained grafting
PLA of low molecular weight, named PHEA-PLA [15,30] has been phys-
icallymixedwith PLLA to test if TIPS technique could allow polymers in-
terpenetration. In particular, it has been investigated how blending
inﬂuenced TIPS with respect to the possibility to control porosity.
Then, scaffold physical properties such as wettability and hydrolytic re-
absorption into buffered physiologic medium have been evaluated.
PHEA-PLA and PLA (12 kDa) have been characterized via FT-IR,
1HNMR and DSC analysis. The results compared as reported into the
supplementary material. For experiments performed in this work the
degree of derivatization percentage in PLA (DD%) onto the PHEA-PLA
derivative was 5 ± 2 mol%.
Different PLLA/PHEA-PLA scaffolds have been obtained from 87/13
(v/v) dioxane/water solution, at different polymers concentration (4, 5
and 6% wt/wt) and demixing temperature (22.5, 25, 30 or 33 °C). Thesolutions have been heated at 65 °C while continuously stirred in
order to achieve a homogeneous clear solution. PHEA-PLA stability, at
the condition of temperature and time for TIPS procedure, was assessed
via SEC. This experiment was carried out for 120 min (which corre-
sponds to the time needed for scaffolds production) at 65 °C. Molecular
weight, retention time and area peaks were registered and reported in
Table 1.
No signiﬁcant alterations on PHEA-PLA Mw from 5 to 120 min were
found, thus suggesting that copolymer stability is maintained with
these operative conditions.
TIPS method offers the possibility to control pore size by varying the
experimental condition and provides means to control pore structure.
The porosity of the scaffolds can be increased by decreasing polymer
concentration and ﬁnal size of pore is the result of balancing between
nucleation and growth processes [31]. Fig. 1 reports SEM images of
PLLA/PHEA-PLA scaffolds obtained under different polymer concentra-
tions and demixing temperature, for a well-deﬁned demixing time
(30 min). A polymer concentration of 6% has led to scaffolds with few
pores, poorly interconnected, independently of demixing temperature
used (33, 30 or 25 °C). In the samples prepared using a polymer concen-
tration of 5%wt/wt, it was possible to observe an increase of pore size by
decreasing demixing temperature from 30 °C to 22.5 °C. Even if a sensi-
ble modiﬁcation in terms of pore size has been obtained, the level of
pore interconnection remains still unsatisfactory. Largest pores and ho-
mogeneous porosity have been obtained when setting up the polymer
concentration at 4% and the demixing temperature at 22.5 °C. A high
level of interconnection has been achieved as well as the formation of
micropores (about 1–2 μm diameter) in the macropores wall.
Fig. 5. SEM images of PLLA (A–B) and PLLA/PHEA-PLA (C–D) scaffold after DMF treatment. Scale bar corresponds to 200 μm for A and C panels and 30 μm for B and D panels.
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temperature of 22.5 °C were selected for further experiments because
their pore size and interconnection seems to be optimal for cell seeding,
cell penetration and migration during the in vitro cell culture [32].
In Fig. 2 A and B the thermograms of pure PHEA-PLA powder, PLLA
and PLLA/PHEA-PLA scaffolds are shown (the PHEA-PLA was employed
as unprocessed powder and not as porous scaffold because of inefﬁcient
TIPS processing). The PLLA thermogram presents the typical proﬁle of
the semi-crystalline polymer with the melting point at 180 °C and a
melting enthalpy of about 56 J/g. As expected, PHEA-PLA trace conﬁrms
that the polymer is amorphous. The thermogramof the blended scaffold
is partially different from that of pure PLLA in the melting region. As a
matter of fact, the DSC trace exhibits a double peak, determined by
the superposition of melting of two populations of crystals. This can
be clearly understood by looking at the deconvolution of the melting
peaks reported in Fig. 2B. The ﬁrst peak is characterized by a 5 °C
width, a relatively lower enthalpy and a lower melting point (located
at a temperature around 175 °C). The second peak presents a width of
about 10 °C with a relatively larger enthalpy and a melting point
superimposed to that of pure PLLA. All things considered, the major ef-
fect of the presence of PHEA-PLAmoieties in the blend, during polymer
crystallization, consists of inducing the formation of a secondary popu-
lation of small and defective PLLA crystals (having a lower meltingTable 2
% weight loss of the hydrolysed scaffolds.
Day 1 Day 7
PLLA 0.16% ± 3.22·10−5 0.18% ± 4.4·10−5
PLLA/PHEA-PLA 2.70% ± 2.9·10−3 4.51% ± 3.1·10−3point with respect to PLLA). This secondary population accompanies
the primary population of PLLA crystals, having a melting point super-
imposable to that of pure PLLA. On the other hand, the change in melt-
ing enthalpy is of minor relevance.
In order to determine the effective amount of PHEA-PLA incorporat-
ed during the phase separation process, blend scaffolds were treated
with DMF. After DMF treatment, a loss weight equal to 18.43% ± 0.47
has been quantiﬁed. FT-IR analysis on residual scaffold highlighted the
absence of the peaks at 1665 cm−1 and 1542 cm−1 attributable to the
amide I and II of PHEA (Fig. 3). This result conceivably suggests that
PHEA-PLA copolymer was completely removed from scaffold. More-
over, from the quantitative data, it can be assumed that a part of the
copolymer has been lost during scaffold preparation considering that
the starting concentration of PHEA-PLA was equal to the 25 wt%.
Pure PLLA scaffoldwere subjected to the same treatment andused as
control. DSC analyses (Fig. 4) have evidenced that the trace of PLLA does
not change before and after theDMF treatment. Beside, an evidentmod-
iﬁcation occurs in the proﬁle of blended scaffold after the treatment. It is
easy to notice that the proﬁle of PHEA-PLA/PLLA blended scaffold after
treatment is very similar to that pure PLLA, since the double peak disap-
pears and the melting temperature increases until about 180 °C. This
result led us to suppose that during the treatment only the PHEA-PLA
was removed by DMF and conﬁrms the efﬁciency of the method.Day 14 Day 28 Day 56
0.55% ± 7.2·10−3 1.06 ± 2.2·10−3 2.02% ± 5.3·10−3
8.24% ± 2.9·10−3 9.74% ± 2.9·10−3 18.98% ± 3.5·10−3
Fig. 6. FT-IR overlay spectra of PLLA/PHEA-PLA scaffold after 1 day (dash line) and 56 days
(continuous line) DPBS incubation.
Fig. 7. Chondrocytes viability results fromMTS assay after 0, 24, 48 and 72 h from seeding.
567F. Carfì Pavia et al. / Materials Science and Engineering C 67 (2016) 561–569Furthermore, it has been demonstrated that the extraction of PHEA-
PLA changes the scaffold structure. SEM analysis on PLLA/PHEA-PLA
scaffold after DMF treatment, reported in Fig. 6c and 6d, showed that al-
though a homogenous porosity has been maintained, the superﬁcial
structure of single pores appeared indented. Conversely, the surface of
the PLLA scaffolds remains unchanged after the same treatment (Fig. 5
A and B). Thus, it is possible to hypothesize that PHEA-PLA copolymer
is distributed uniformly into the scaffold thank to an interpenetration
occurred between the two polymers during the phase separation.
3.2. Swelling and weight loss studies
PLLA/PHEA-PLA scaffolds have been incubated with DPBS pH 7.4
until 56 days using PLLA scaffolds as comparison (see experimental sec-
tion). Swelling behaviour has been determined as a function of time and
expressed as the swelling weight ratio (q) between WS and Wi. It has
been obtained a q value equal to 16.30 ± 0.13 for PLLA/PHEA-PLA scaf-
folds and equal to 12.42 ± 0.02 for PLLA scaffolds. Both values do not
undergo statistically signiﬁcant changes during the 56 days. In Table 2
theweight loss percent of samples after 1, 7, 14, 28 and 56 days of incu-
bation has been reported. In PLLA scaffolds a modest weight loss after
56 days has been conﬁrmed, as were described in a previous work
[26]. Instead, in PLLA/PHEA-PLA scaffolds a statistically signiﬁcant
(p b 0.05 just after the ﬁrst day of incubation) progressive increase in
weight loss with time was observed.
These results conﬁrm that the presence of PHEA-PLA on composite
scaffold, increased afﬁnity for biological ﬂuids if compared to
PLLA scaffold. Beside network compactness, water penetration and
swelling ratio remained unchanged indicating of hydrophobic
PLLA structure remained the same. FT-IR spectra of PLLA/PHEA-PLA
scaffolds after 1 and 56 days of incubation were compared (Fig. 6). Al-
though theweight losswas statistically signiﬁcant, it was demonstrated
that PHEA-PLA copolymer is still present in the scaffold after 56 days of
incubation.
All these results suggest that PHEA-PLA and PLLA interpenetrated,
giving rise to stable and durable scaffolds. This interpenetration causes
a scaffold degradation involving both PLLA and PHEA-PLA and signiﬁ-
cantly improves the rate of hydrolysis if compared to the scaffold of
pure PLLA.
3.3. In vitro cells compatibility study
A preliminary biological evaluation of scaffoldswas performed using
bovine chondrocytes. Chondrocytes were seeded at low density
(105 cells for construct) and proliferation followed for 3 days just to
assay cell loading, viability and initial growth, and attachment of cells.
Viability of seeded chondrocytes has been evaluated by MTS. Obtained
results have been compared to those found using PLLA scaffolds.
Fig. 7 shows the growth of the cells into the two different scaffolds as
a function of time. An evident and statistically signiﬁcant cell growth
(p ≤ 0.05) inside the PLLA scaffoldwas observed just after 24 h, followed
by a slight and not statistically signiﬁcant increase in the further 48 h. In
the case of PLLA/PHEA-PLA scaffold, a continuous growth was observed
during thewhole culture time being statistically signiﬁcant from time 0
to 24 h and from 48 to 72 h (p ≤ 0.05).
The SEMmicrographs in Fig. 8 show cells morphologies seeded into
the two scaffolds. Immediately after the seeding, the cells growing into
the PLLA/PHEA-PLA scaffold appear spread andwell adhered to the sur-
face, whereas those growing into pure PLLA scaffold appears with pseu-
do-spherical morphology. Moreover, the cells on blend scaffold start to
take contact each other through protrusions detectable at highmagniﬁ-
cation. Conversely, the cells seeded into the PLLA scaffold present few
protrusions or in some cases did not present them. The described mor-
phologies could indicate a higher level of cell-substrate interaction in
the PLLA/PHEA-PLA scaffolds.The higher cellular afﬁnity towards the composite scaffold with re-
spect to PLLA scaffold could be associated, in addition to the chemical
structure of PHEA, to the fast hydrolysis rate detected in the composite
scaffold. As a matter of fact, the increased afﬁnity for biological ﬂuids
given by the presence of PHEA, could promote a higher level of cell
adhesion.
Taken together SEM images and MTS data let us to suppose that the
presence of PHEA increases material cells afﬁnity.
4. Conclusion
Porous scaffolds for tissue engineering applications have been real-
ized via TIPS by using blends of PLLA with PHEA-PLA. These new com-
posite structures offer both the opportune crystallinity of PLLA,
necessary for the production of scaffolds trough a TIPS method, and
the higher water afﬁnity and faster rate of hydrolysis of PHEA-PLA.
Various PLLA/PHEA-PLA scaffolds with variable porosity have been
obtained bymodifying polymers concentration and demixing tempera-
ture. Obtained results have conﬁrmed that it is possible to achieve struc-
tures with an open porosity and a good level of interconnection. DSC
results allowed to assume that PHEA-PLA copolymer, during polymer
crystallization, would lead to the formation of small and defective
PLLA crystals in addition to the primary population of PLLA crystals.
The reached progressive increase in weight loss with time in PLLA/
PHEA-PLA scaffolds could be conceivably due to the polymers interpen-
etration, the control of PLLA crystallinity and the enhanced water
afﬁnity.
Fig. 8. SEM images of PLLA/PHEA-PLA and PLLA scaffold after 24 h of cells seeding.
568 F. Carfì Pavia et al. / Materials Science and Engineering C 67 (2016) 561–569The faster rate of hydrolysis of PLLA/PHEA-PLA scaffolds in physio-
logic media seems not to interfere with the scaffold cellular afﬁnity.
From the achieved in vitro results achieved in fact appears that the pres-
ence of PHEA improved thematerial afﬁnity towards the cells inside the
scaffold.
All things considered, the results presented in this paper candidate
PLLA/PHEA–PLLA scaffolds as a new construct with signiﬁcant potential
in tissue engineering applications.Acknowledgments
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